Cost-Effectiveness of Risk Score–Stratified Hepatocellular Carcinoma Screening in Patients with Cirrhosis

机译：风险评分对肝硬化患者分层肝细胞癌筛查的成本-效果

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

Objectives:Hepatocellular carcinoma (HCC) surveillance with biannual ultrasound is currently recommended for all patients with cirrhosis. However, clinical implementation of this “one-size-fits-all” approach is challenging as evidenced by its low application rate. We aimed to evaluate the cost-effectiveness of risk-stratified HCC surveillance strategies in patients with cirrhosis.

机译：目的：目前建议对所有肝硬化患者进行半年一次的肝细胞癌（HCC）监测。但是，这种“千篇一律”的方法在临床上具有挑战性，这是因为它的应用率低。我们旨在评估肝硬化患者风险分层的HCC监测策略的成本效益。

著录项

期刊名称 Clinical and Translational Gastroenterology
作者
Nicolas Goossens; Amit G Singal; Lindsay Y King; Karin L Andersson; Bryan C Fuchs; Cecilia Besa; Bachir Taouli; Raymond T Chung; Yujin Hoshida;
展开▼
作者单位

展开▼
年(卷),期 2017(8),6
年度 2017
页码 e101
总页数 9
原文格式 PDF
正文语种
中图分类肠道病毒与肝炎病毒;肝及胆疾病;肠疾病;
关键词

相似文献

外文文献
中文文献
专利

1. Cost-Effectiveness of Risk Score|[ndash]|Stratified Hepatocellular Carcinoma Screening in Patients with Cirrhosis [J] . NicolasGoossens, Amit GSingal, Lindsay YKing, Clinical and Translational Gastroenterology . 2017,第6期

机译：风险评分的成本-效果| ndash |肝硬化患者分层肝细胞癌筛查
2. Cost-effectiveness of a risk-stratified hepatocellular carcinoma surveillance strategy in patients with cirrhosis [J] . Goossens Nicolas, Singal Amit G., King Lindsay Y., Hepatology: Official Journal of the American Association for the Study of Liver Diseases . 2016,第S1期

机译：肝硬化患者风险分层肝细胞癌监测策略的成本效益
3. ALBI-T: A Score Based on Albumin, Bilirubin and TNM Stratifies Patients with Child A Cirrhosis and Hepatocellular Carcinoma [J] . Elshaarawy Omar A., Gomaa Asmaa, Allam Naglaa A., Hepatology: Official Journal of the American Association for the Study of Liver Diseases . 2016,第S1期

机译：Albi-T：基于白蛋白，胆红素和TNM分层儿童肝硬化和肝细胞癌的分数
4. Hepatocellular carcinoma, cholangiocarcinoma, colon and pancreatic carcinoma in patients with primary sclerosing cholangitis: epidemiology and risk factors [C] . U. BROOME, A. BERGQUIST Falk Liver Week . 2004

机译：肝细胞癌，胆管癌，结肠癌和初级硬化性胆管炎患者的胰腺癌：流行病学和风险因素
5. Cost-effectiveness analysis of a 2-stage community-based hepatocellular carcinoma screening program in Taiwan [D] . Chang, Yaojen 2008

机译：台湾一项基于社区的2期肝细胞癌筛查计划的成本效益分析
6. External Validation of aMAP Hepatocellular Carcinoma Risk Score in Patients With Chronic Hepatitis B-Related Cirrhosis Receiving ETV or TDF Therapy [O] . Honglian Gui, Yan Huang, Gangde Zhao, 2021

机译：慢性乙型肝炎相关肝硬化患者AMAP肝细胞癌风险评分的外部验证接受ETV或TDF治疗
7. Cost-Effectiveness of Risk Score–Stratified Hepatocellular Carcinoma Screening in Patients with Cirrhosis [O] . Nicolas Goossens, Amit G Singal, Lindsay Y King, 2017

机译：肝硬化患者风险评分分层肝细胞癌筛查的成本效益

Cost-Effectiveness of Risk Score–Stratified Hepatocellular Carcinoma Screening in Patients with Cirrhosis

摘要

著录项

相似文献

相关主题

期刊订阅